Page 105 - 《中国药房》2023年7期
P. 105

固肾安胎丸联合达肝素钠治疗ACA阳性复发性流产的临床观察
                                                                                                           Δ


                *
          张 丽 ,董冰莹,袁小丽(三二〇一医院妇科,陕西 汉中 723000)
          中图分类号  R984      文献标志码  A      文章编号  1001-0408(2023)07-0863-05
          DOI  10.6039/j.issn.1001-0408.2023.07.18

          摘  要  目的  探讨固肾安胎丸联合达肝素钠对抗心磷脂抗体(ACA)阳性复发性流产患者的临床疗效。方法  将ACA阳性复发
          性流产患者203例随机分为对照组(n=101)和联合治疗组(n=102)。对照组患者在基础治疗的基础上采用达肝素钠治疗,联合
          治疗组患者在对照组治疗的基础上加用固肾安胎丸治疗。收集患者血清样本,采用酶联免疫吸附试验法检测2组患者血清白细
          胞介素6(IL-6)、肿瘤坏死因子α(TNF-α)、环氧化酶2(COX-2)、β人绒毛膜促性腺激素(β-HCG)、ACA 水平并计算抗体转阴率,观
          察患者的临床疗效,同时记录不良反应发生情况。结果  治疗后,联合治疗组患者的妊娠成功率和抗体转阴率均显著高于对照组
         (P<0.05),流产率显著低于对照组(P<0.05);2 组患者血清 IL-6、TNF-α、ACA 水平均较治疗前显著下降(P<0.05),COX-2、β-
          HCG水平均较治疗前显著升高(P<0.05),且联合治疗组患者上述指标水平变化更显著(P<0.05)。2组患者不良反应发生率比
          较,差异无统计学意义(P>0.05)。结论  固肾安胎丸可通过上调ACA阳性复发性流产患者血清COX-2水平、下调IL-6水平来维
          持β-HCG的高表达,降低ACA水平,改善免疫微环境,从而提高妊娠成功率。
          关键词  复发性流产:固肾安胎丸;达肝素钠;抗心磷脂抗体;临床疗效

          Clinical observation of Gushen antai pill combined with heparin sodium in the treatment of anticardiolipin
          antibody-positive recurrent abortion
          ZHANG Li,DONG Bingying,YUAN Xiaoli(Dept.  of  Gynaecology,  No.  3201  Hospital,  Shaanxi  Hanzhong
          723000, China)

          ABSTRACT     OBJECTIVE  To  investigate  the  clinical  efficacy  of  Gushen  antai  pills  combined  with  heparin  sodium  in  the
          treatment  of  antiphospholipin  antibody (ACA)-positive  recurrent  abortion.  METHODS  A  total  of  203  ACA-positive  recurrent
          abortion  patients  were  randomly  divided  into  control  group (n=101)  and  combination  treatment  group (n=102).  Control  group
          was additionally treated with heparin sodium on basis of basic treatment, and combination treatment group was additionally treated
          with Gushen antai pills on the basis of control group. Serum samples were collected from patients, the levels of interleukin 6 (IL-
          6),  tumor  necrosis  factor  α (TNF-α),  cyclooxygenase  2 (COX-2),  β-human  chorionic  gonadotropin (β-HCG)  and ACA  were
          detected  by  enzyme-linked  immunosorbent  assay. The  antibody-negative  conversion  rate  was  calculated,  the  clinical  efficacy  of  the
          patient  was  observed,  and  the  occurrence  of  adverse  drug  reactions  was  recorded.  RESULTS  After  treatment,  the  pregnancy
          success rate and antibody-negative conversion rate of combination treatment group were significantly higher than those in the control
          group (P<0.05),  and  the  abortion  rate  was  significantly  lower  than  that  in  the  control  group (P<0.05).  Compared  with  before
          treatment, serum levels of IL-6, TNF-α and ACA in 2 groups were decreased significantly (P<0.05), while the levels of COX-2
          and  β -HCG  were  increased  significantly (P<0.05);  the  changes  of  above  indexes  in  combination  treatment  group  were  more
          significant(P<0.05).  There  was  no  statistical  significance  in  the  incidence  of  adverse  drug  reactions  between  2  groups(P>0.05).
          CONCLUSIONS  Gushen  antai  pills  can  maintain  high  expression  of  β -HCG,  reduce  the  level  of  ACA  and  improve  immune
          microenvironment  in  patients  with  ACA-positive  recurrent  abortion  by  increasing  the  serum  level  of  COX-2  and  decreasing  the
          serum level of IL-6, so as to increase the success rate of pregnancy.
          KEYWORDS    recurrent abortion; Gushen antai pill; heparin sodium; anticardiolipin antibody; clinical efficacy


              复发性流产常继发于多种疾病,有报道称其与遗                          起的一组反复动脉或静脉血栓、自然流产、ACA 阳性等
                                 [1]
          传、激素和子宫等因素有关 。目前,抗心磷脂抗体(an‐                        临床问题的总称,其中产科并发症如胎儿死亡、早产、先
                                                                                                 [2]
          ticardiolipin antibody,ACA)已被确认为复发性流产的重            兆子痫和反复性流产是APS的特征性表现 。在自身免
          要因素之一,两者之间的关联已得到广泛认证 。抗磷                           疫因素中,ACA引发的APS在复发性流产女性中的患病率
                                                  [1]
                                                                     [3]
          脂综合征(antiphospholipid syndrome,APS)是由ACA引          高达40% ,目前的治疗方案以免疫抑制和抗凝为主。
                                                                 固肾安胎丸由制何首乌、地黄、肉苁蓉(制)、续断、
             Δ 基金项目 陕西省科技发展计划项目(No.2021B00200)
                                                             桑寄生、钩藤、菟丝子、白术(炒)、黄芩、白芍制成,具有
             *第一作者 副主任医师,硕士。研究方向:妇科肿瘤、生殖医学。
          E-mail:zhanglillian3201@126.com                    滋阴补肾、固冲安胎的功效,适用于早期先兆流产的治


          中国药房  2023年第34卷第7期                                                 China Pharmacy  2023 Vol. 34  No. 7    · 863 ·
   100   101   102   103   104   105   106   107   108   109   110